Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Treatment Type

  2.3.2 Market Size By Route of Administration

  2.3.3 Market Size By Drug Class

  2.3.4 Market Size By End User

 2.3.5 Market Size By Distribution Channel

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

 4.1 Pricing Analysis & Forecast

  4.1.1 Overview

  4.1.2 Pricing Analysis & Forecast By Treatment Type, 2022–2035

  4.1.3 Price Benchmarking By Key Therapy Providers, 2025

 4.2 Regulatory & Clinical Development Landscape

  4.2.1 Overview

  4.2.2 FDA & EMA Regulatory Pathway Analysis

  4.2.3 Clinical Trial Trends for Novel Celiac Therapies

 4.3 Treatment & Drug Development Trends

  4.3.1 Gluten-Free Diet Adoption & Compliance Analysis

     4.3.2 Enzyme Replacement & Immunotherapy Development Trends

     4.3.3 Biologics & Small Molecule Pipeline Assessment

 4.4 Patient Demographics & Disease Burden Trends

  4.4.1 Diagnosed Patient Population Analysis By Region

     4.4.2 Pediatric vs Adult Treatment Demand Trends

     4.4.3 Autoimmune Comorbidity & Nutritional Deficiency Trends

 4.5 Distribution & Healthcare Access Trends

  4.5.1 Hospital vs Retail Pharmacy Distribution Analysis

     4.5.2 Online Pharmacy & Direct-to-Consumer Supplement Growth

     4.5.3 Specialty Clinic & Homecare Treatment Adoption Trends

5. Celiac Disease Treatment Market Segmental Analysis & Forecast, By Treatment Type, 2022–2035, Value (USD Billion)

5.1 Introduction                                                 

 5.2 Gluten-Free Diet Management

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Enzyme Replacement Therapy

 5.4 Immunomodulators

 5.5 Steroids & Vitamins/Minerals Supplementation

 5.6 Others

6. Celiac Disease Treatment Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Oral

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Injectable

 6.4 Others

7. Celiac Disease Treatment Market Segmental Analysis & Forecast, By Drug Class, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Biologics

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Small Molecules

 7.4 Nutritional Supplements

8. Celiac Disease Treatment Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals & Specialty Clinics

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Research Centers

 8.4 Homecare Settings

9. Celiac Disease Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2022–2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospital Pharmacies

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022–2035 

  9.3 Retail Pharmacies

  9.4 Online Pharmacies 

10. Celiac Disease Treatment Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Celiac Disease Treatment Market Size & Forecast, By Treatment Type, 2022–2035

  10.2.3 Celiac Disease Treatment Market Size & Forecast, By Route of Administration, 2022–2035

  10.2.4 Celiac Disease Treatment Market Size & Forecast, By Drug Class, 2022–2035

  10.2.5 Celiac Disease Treatment Market Size & Forecast, By End User, 2022–2035

  10.2.6 Celiac Disease Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

  10.2.7 Celiac Disease Treatment Market Size & Forecast, By Country, 2022–2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Celiac Disease Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.3.3 Celiac Disease Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.3.4 Celiac Disease Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.3.5 Celiac Disease Treatment Market Size & Forecast, By End User, 2022–2035

 10.3.6 Celiac Disease Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.3.7 Celiac Disease Treatment Market Size & Forecast, By Country, 2022–2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Celiac Disease Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.4.3 Celiac Disease Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.4.4 Celiac Disease Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.4.5 Celiac Disease Treatment Market Size & Forecast, By End User, 2022–2035

 10.4.6 Celiac Disease Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.4.7 Celiac Disease Treatment Market Size & Forecast, By Country, 2022–2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Celiac Disease Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.5.3 Celiac Disease Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.5.4 Celiac Disease Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.5.5 Celiac Disease Treatment Market Size & Forecast, By End User, 2022–2035

 10.5.6 Celiac Disease Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.5.7 Celiac Disease Treatment Market Size & Forecast, By Country, 2022–2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Celiac Disease Treatment Market Size & Forecast, By Treatment Type, 2022–2035

 10.6.3 Celiac Disease Treatment Market Size & Forecast, By Route of Administration, 2022–2035

 10.6.4 Celiac Disease Treatment Market Size & Forecast, By Drug Class, 2022–2035

 10.6.5 Celiac Disease Treatment Market Size & Forecast, By End User, 2022–2035

 10.6.6 Celiac Disease Treatment Market Size & Forecast, By Distribution Channel, 2022–2035

 10.6.7 Celiac Disease Treatment Market Size & Forecast, By Country, 2022–2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 South Africa

  10.6.7.5 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Treatment Type/Service & Route of Administration Benchmarking

  11.4.1 Treatment Type/Service Specifications & Features By Key Players

  11.4.2 Treatment Type/Service Heatmap By Key Players

  11.4.3 Route of Administration Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

 11.6.1 Takeda Pharmaceutical Company Ltd.

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Treatment Type/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 SWOT Analysis

 11.6.2 ImmusanT Inc.

 11.6.3 Chugai Pharmaceutical Co. Ltd.

 11.6.4 Alvine Pharmaceuticals Inc.

 11.6.5 9 Meters Biopharma Inc.

 11.6.6 GlaxoSmithKline PLC

 11.6.7 Bioniz Therapeutics

 11.6.8 Protagonist Therapeutics

 11.6.9 Aimmune Therapeutics (Nestle Health Science)

 11.6.10 Dr. Schär AG/SpA

 11.6.11 Glutelief by Bioxcel Therapeutics

 11.6.12 Cour Pharmaceutical Development

 11.6.13 Artisan Biopharma

 11.6.14 Bioatla LLC

 11.6.15 Zealand Pharma A/S

 11.6.16 Forte Biosciences Inc.

 11.6.17 Celimmune LLC

 11.6.18 Larazotide Acetate (9 Meters Bio)

 11.6.19 Entasis Therapeutics

 11.6.20 Intrexon Corporation

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures